ANKARA, Turkey — Turkey on Thursday expanded its COVID-19 inoculation campaign to include people aged 85 and older.
The country of 83 million rolled out its vaccination drive a week ago, starting with health care workers as well as nursing home residents and their care-givers. More than 1 million people received the first of two doses of the vaccine developed by China’s Sinovac pharmaceutical company in the first week.
On Thursday, the more frail among those aged 85 and above were receiving their shots at home, while others made their way to health centers.
Turkey has so far received 3 million doses of the Sinovac vaccine. President Recep Tayyip Erdogan has said Turkey is scheduled to receive between 25 and 30 million more doses, although there has been no word on when the additional doses will arrive.
Turkey has reported close to 2.4 million infections and more than 24,000 deaths since March.
LONDON (AP) — A mammoth three-year public inquiry into the U.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.06 USD
